Attar Eyal C. is Chief Medical Officer of Vor Biopharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Vor Biopharma Inc.
9 Aug 23
4
Vor Biopharma Inc.
10 May 23
4
Vor Biopharma Inc.
8 Feb 23
4
Vor Biopharma Inc.
12 Oct 22
3
Vor Biopharma Inc.
12 Oct 22
4
Aprea Therapeutics, Inc.
7 Jun 22
4
Aprea Therapeutics, Inc.
14 Mar 22
4
Aprea Therapeutics, Inc.
1 Mar 22
4
Aprea Therapeutics, Inc.
20 Sep 21
4
Aprea Therapeutics, Inc.
27 Aug 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Aug 23 | VOR Vor Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 2.67 | 999 | 2.67 k | 52,532 |
| 8 May 23 | VOR Vor Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 4.14 | 969 | 4.01 k | 53,531 |
| 6 Feb 23 | VOR Vor Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 54,500 | 0.00 | 54,500 |
| 6 Feb 23 | VOR Vor Biopharma | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.55 | 109,000 | 604.95 k | 109,000 |
| 11 Oct 22 | VOR Vor Biopharma | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 3.77 | 364,000 | 1.37 mm | 364,000 |